Central Washington University Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2013
NCT03889431
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Central Washington University & Hawassa University

Active Ingredients

Drugs in Other Trials (2)

iodized salt (1 trial)

potassium iodide (thyro-block) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2